Benzofuran acetamide compound containing propanolamine structure and application thereof
A technology of benzofuran and compounds, which is applied to benzofuran acetamide compounds. Its application field as a β-receptor blocker can solve the problems of different side effects of antihypertensive drugs, and achieve good hypertension, The effect of good application value and good development and application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Example 1: Preparation of 1-(4-morpholinyl)-2-{6-[2-hydroxyl-3-(isopropylamino)propoxy]benzofuran-3-yl}ethanone (TX01)
[0048] Step A: Preparation of 1-(4-morpholinyl)-2-(6-hydroxybenzofuran-3-yl)ethanone
[0049] 2-(6-Hydroxy-1-benzofuran-3-yl)acetic acid (5.7g, 30mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodi Imine hydrochloride (EDCI, 8.0g, 42mmol), 1-hydroxybenzotriazole (HOBt, 5.7g, 42mmol), morpholine (90mmol) and 90mL of dry dichloromethane, refluxed for 24h, and the reaction solution was washed with 20mL Wash three times with 6% hydrochloric acid, wash three times with 20mL 5% sodium hydroxide solution, wash twice with 20mL saturated sodium chloride solution, dry the organic layer with anhydrous magnesium sulfate, remove the solvent by rotary evaporation, and perform column chromatography [petroleum ether: ethyl acetate (V:V)=3:1], 3.3 g of white solid was obtained, and the yield was 42.1%. m.p.: 176-179°C. ESI-MS(m / z):262.1([M+H] + ); 1 H-NMR (400MHz, CD...
Embodiment 2
[0054] Example 2: Preparation of 1-(4-morpholinyl)-2-{6-[2-hydroxyl-3-(tert-butylamino)propoxy]benzofuran-3-yl}ethanone (TX02)
[0055] Referring to the preparation method of Example 1, 0.82 g of yellow solid was obtained, yield: 52.8%. m.p.: 146-148°C. ESI-MS(m / z):391.2([M+H] + ); 1 H-NMR (600MHz, CDCl 3 )δ7.46(s,1H),7.45(d,J=8.5Hz,1H),7.01(d,J=2.1Hz,1H),6.90(dd,J 1 =8.6Hz,J 2 =2.2Hz,1H),4.07-4.10(m,1H),4.04(dd,J 1 =9.3Hz,J 2 =5.3Hz,1H),4.00(dd,J 1 =9.3Hz,J 2 =5.0Hz,1H),3.72(s,2H),3.65(s,4H),3.56–3.53(m,2H),3.50–3.47(m,2H),2.95(dd,J 1 =12.0Hz,J 2 =3.6Hz,1H),2.77(dd,J 1 =11.9Hz,J 2 =8.1Hz, 1H), 1.19(s, 9H).
Embodiment 3
[0056] Example 3: Preparation of N,N-diethyl-2-{6-[2-hydroxy-3-(isopropylamino)propoxy]benzofuran-3-yl}acetamide (TX03)
[0057] Referring to the preparation method of Example 1, 0.84 g of light yellow solid was obtained, yield: 58.3%. m.p.: 167-169°C. ESI-MS(m / z):363.2([M+H] + ); 1 H-NMR (600MHz, CDCl 3 )δ7.45(s,1H),7.41(d,J=8.6Hz,1H),6.96(d,J=2.0Hz,1H),6.85(dd,J 1 =8.6Hz,J 2 =2.1Hz, 1H), 4.47(d, J=4.9Hz, 1H), 4.05(dd, J 1 =9.6Hz,J 2 =4.7Hz,1H),3.97(dd,J 1 =9.5Hz,J 2 =5.7Hz,1H),3.65(s,2H),3.38(q,J=7.1Hz,2H),3.34(q,J=7.1Hz,2H),3.31-3.26(m,1H),3.18(dd ,J 1 =12.3Hz,J 2 =2.4Hz,1H),3.04(dd,J 1 =11.8Hz,J 2=9.1Hz, 1H), 1.39–1.32(m, 6H), 1.15(t, J=7.1Hz, 3H), 1.11(t, J=7.1Hz, 3H).
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


